Sort
48,018 grants matching “immunotherapy”
Enhancing T Cell Therapy of Cancer
$1,992,319Helen E Heslop · Baylor College Of Medicine · P01 · FY2010 · CA
Modulating Cancer Stem Cell Signaling in Thoracic Malignancies
$1,992,211David Schrump · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
High-Dimensional Immune Monitoring of NCI-Supported Immunotherapy Trials
$1,992,193Sacha Gnjatic · Icahn School Of Medicine At Mount Sinai · U24 · FY2025 · CA
Development of an Integrated Canine Data Commons (ICDC)
$1,991,470John Otridge · Leidos Biomedical Research, Inc. · N01 · FY2018 · CA
Blood Stem Cell Transplantation as Immunotherapy
$1,991,366Samuel Strober · Stanford University · P01 · FY2006 · HL
Center for Immunotherapeutic Transport Oncophysics
$1,990,957Mauro Ferrari · Methodist Hospital Research Institute · U54 · FY2016 · CA
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
$1,990,761Thomas Waldmann · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Novel Targets for Immunotherapy
$1,989,744Claudia Palena · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Noroviruses and Epidemic Gastroenteritis
$1,988,093Kim Y. Green · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
MD Anderson Cancer Center SPORE in Gastrointestinal Cancer
$1,987,442Scott Kopetz · University Of Tx Md Anderson Can Ctr · P50 · FY2021 · CA
Innate Immunity: Elucidation and Modulation for Cancer Therapy
$1,987,279Michael A Caligiuri · Ohio State University · P01 · FY2007 · CA
COMBINATION IMMUNOTHERAPY FOR THE TREATMENT OF HIGH RISK HER2 POSITIVE BREAST CANCER
$1,987,155The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2014 · Department of the Army
Genetics and Biology of Pancreatic Ductal Adenocarcinoma
$1,986,783Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2017 · CA
Innate Immunity: Elucidation and Modulation for Cancer Therapy
$1,986,616Michael A Caligiuri · Ohio State University · P01 · FY2014 · CA
The Role of Cytopathology in Biomedical Research
$1,986,606Andrea Abati · Basic Sciences · Z01 · FY2007 · CA
Blood Stem Cell Transplantation as Immunotherapy
$1,985,980Stanford University · P01 · FY2005 · HL
Mixed Hematopoietic Chimerism after Stem Cell Allografts
$1,985,492Rainer F. Storb · Fred Hutchinson Cancer Research Center · P01 · FY2007 · CA
Colon Cancer Family Registry Cohort
$1,985,187Mark A Jenkins · University Of Melbourne · U01 · FY2019 · CA
First-in-Human (Phase 1) Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of IBC-Ab002 in Persons with Early Alzheimer's Disease (AD)
$1,984,624Eti Yoles · Immunobrain Checkpoint Inc. · R01 · FY2021 · AG
Host-tumor cell interaction in myeloma: therapeutic applications
$1,984,614Kenneth C Anderson · Dana-Farber Cancer Inst · P01 · FY2011 · CA
Duke SPORE in Brain Cancer
$1,984,462John H Sampson · Duke University · P50 · FY2020 · CA
Genes and signals controlling mammalian hematopoiesis.
$1,984,290Paul E Love · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2017 · HD
ADULT AIDS CLINICAL TRIALS UNIT
$1,984,093Indiana Univ-Purdue Univ At Indianapolis · U01 · FY2001 · AI
Genetic Approaches to Cancer Immunotherapy
$1,984,035Michel Sadelain · Sloan-Kettering Inst Can Research · P01 · FY2007 · CA
High-Dimensional Immune Monitoring of NCI-Supported Immunotherapy Trials
$1,983,570Sacha Gnjatic · Icahn School Of Medicine At Mount Sinai · U24 · FY2023 · CA